{"database": "openregs", "table": "documents", "rows": [["FDA-2017-D-5928-0007", "FDA", "FDA-2017-D-5928", "Post-Complete Response Letter Meetings Between the Food and Drug\nAdministration and Abbreviated New Drug Application Applicants Under\nGeneric Drug User Fee Amendments; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2018-12-04T05:00:00Z", 2018, 12, "2018-12-04T05:00:00Z", null, "2022-10-05T19:15:10Z", "2018-26285", 0, 0, "0900006483939624"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2017-D-5928-0007"], "units": {}, "query_ms": 0.28831500094383955, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}